17Beta-Hydroxy-17Alpha-methylandrost-4-eno[3,2-c]pyrazole
CAS: 5697-57-4
Ref. TR-H804545
1mg | Descontinuado | ||
5mg | Descontinuado | ||
10mg | Descontinuado | ||
2500µg | Descontinuado |
Informação sobre produto
- (17β)-17-Methyl-1'H-androst-4-eno[3,2-c]pyrazol-17-ol
- 1,2,3,3a,3b,4,5,8,10,10a,10b,11,12,12a-Tetradecahydro-1,10a,12a-trimethylcyclopenta[7,8]phenanthro[2,3-c]pyrazol-1-ol
- 17-Methyl-1'H-androst-4-eno[3,2-c]pyrazol-17β-ol
- Cyclopenta[7,8]phenanthro[2,3-c]pyrazole, 1'H-androst-4-eno[3,2-c]pyrazol-17-ol deriv.
- 17b-Hydroxy-17-methylandrost-4-eno[3,2-c]pyrazole
- 17β-Hydroxy-17α-methylandrost-4-eno[3,2-c]pyrazole
- 1′H-Androst-4-eno[3,2-c]pyrazol-17-ol, 17-methyl-, (17β)-
- 1′H-Androst-4-eno[3,2-c]pyrazol-17β-ol, 17-methyl-
- 5697-57-4
- Cyclopenta[7,8]phenanthro[2,3-c]pyrazol-1-ol, 1,2,3,3a,3b,4,5,8,10,10a,10b,11,12,12a-tetradecahydro-1,10a,12a-trimethyl-
- Ver mais sinónimos
- Cyclopenta[7,8]phenanthro[2,3-c]pyrazole, 1′H-androst-4-eno[3,2-c]pyrazol-17-ol deriv.
- Hydroxystenozole
- Hydroxystenozole [INN]
- NSC 43194
Applications 17β-Hydroxy-17α-methylandrost-4-eno[3,2-c]pyrazole is an intermediate in the synthesis of metabolite of the anabolic androgenic steroid Stanozolol (S684500).
References Schaenzer, W. et al.: Anal. Chim. Acta, 275, 23 (1993); Schaenzer, W. et al.: J. Chrom. B Biomed Appl., 687, 93 (1996); Guddat, S. et al.: Drug Test. Anal., 1, 545 (2009);